Sentences with phrase «breast radiotherapy»

PRIME 2 is an international, phase III, randomized, controlled trial that set out to address the question of whether whole - breast radiotherapy can be omitted in carefully defined groups of older patients receiving appropriate therapy.

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet.

Following breast conserving surgery, some patients were treated with whole breast radiotherapy — the clinical standard — while others received partial breast radiotherapy.

Following presentation of the initial results, the UK Royal College of Radiologists 2016 breast radiotherapy consensus stated that partial breast radiotherapy could be considered for selected patients using the IMPORT LOW technique.

She was treated with partial breast radiotherapy as part of the trial.

In addition, the Danish Breast Cancer Oncology Group also adopted this partial breast radiotherapy technique for selected patients.

Not exact matches

Some breast centers carry out not only the testing procedures but also treatments (chemotherapy, radiotherapy, etc.) and even restorative surgery if a woman has had part or all of her breast removed.

Breast Cancer Care comments on NICE recommendation of new breast cancer radiotherapy treBreast Cancer Care comments on NICE recommendation of new breast cancer radiotherapy trebreast cancer radiotherapy treatment

«Intrabeam radiotherapy is another exciting development and could dramatically improve the quality of life of some women diagnosed with breast cancer, but there is not yet evidence of its long term benefits.

Responding to the announcement from the University of Edinburgh that some older breast cancer patients could safely skip radiotherapy Dr Emma Pennery CBE, Clinical Director at Breast Cancer Care,breast cancer patients could safely skip radiotherapy Dr Emma Pennery CBE, Clinical Director at Breast Cancer Care,Breast Cancer Care, says:

Breast Cancer Care responds to University of Edinburgh research showing some patients can skip radiotherapy

Radiotherapy is still a highly effective treatment for many women with breast cancer.»

That means that roughly 36 of the 190 women who received annual mammography for 10 years and were diagnosed with breast cancer would receive unnecessary surgery, chemotherapy or radiotherapy.

Women who received partial radiotherapy reported fewer long term changes to the appearance and feel of their breast, than those who had radiotherapy to the whole breast.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of coming back.

«Targeted radiotherapy limits side effects of breast cancer treatment.»

The authors had data for 2,679 women (average age 64) with a diagnosis of DCIS between 1990 and 2011 and for 757 women (average age 79) with a DCIS diagnosis between 1991 and 2009 who had not undergone radiotherapy for DCIS and experienced a subsequent breast cancer or DCIS diagnosis.

«Physicians in regions of high use of radiotherapy may guide patients with DCIS toward mastectomy because many of these patients are ineligible for BCS at the time of a second breast event — having already received radiotherapy — leading to mastectomy being recommended for patients who did not receive radiotherapy and are eligible for BCS.

The NIHR - funded researchers, based at The Royal Marsden hospital in London, asked 42 breast cancer patients undergoing radiotherapy to rate how they felt about their body, before the treatment and one month later.

«Invisible tattoos» could improve body confidence after breast cancer radiotherapy.»

The authors report that women who lived in an area with greater radiotherapy with BCS were more likely to undergo mastectomy if they had a second breast cancer even though they were candidates for BCS since they had initially foregone radiotherapy.

Invisible tattoos could replace the permanent dark ink tattoos used to ensure that breast cancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer Conference.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

The difference in breast cancer - free survival between those receiving and not receiving radiotherapy (98.5 percent vs. 96.4 percent), however, was statistically significant.

«We have identified a subgroup of older patients at sufficiently low risk of recurrence for whom omission of postoperative radiotherapy after breast - conserving surgery and adjuvant endocrine therapy is a reasonable option.

«Once a patient has had radiotherapy, they are unable to have it again on the same breast.

«Avoiding radiotherapy is an option for some older patients with breast cancer.»

Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast - conserving surgery for hormone receptor - positive, axillary node - negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10breast - conserving surgery for hormone receptor - positive, axillary node - negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10Breast Cancer Symposium, held Dec. 10 - 14.

Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.

«We have shown that blocking the activity of FAK not only reduces the growth of breast cancer stem cells, but also improves sensitivity to radiotherapy.

Radiotherapy to the chest wall and regional lymph nodes (under the arm, above the collar bone and under the breast bone), known as regional nodal irradiation, is used after mastectomy in women with node - positive breast cancer who are treated with adjuvant systemic therapy.

Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncolradiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncolradiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and OncolRadiotherapy and Oncology (ESTRO).

With regard to radiotherapy for breast cancer, the guidelines provide recommendations on hypofractionated radiotherapy — an aspect currently not considered by the DMP.

One of the aims of external radiotherapy is to treat the target — in this case the whole breast — with an even dose distribution, i.e. within a range of 95 % to 107 % of the prescribed dose.

The remaining nine guidelines address specific aspects such as radiotherapy, breast reconstruction or adjuvant systematic treatment.

Quality of life for women treated with a more targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according...

Among survivors who were previously treated with radiotherapy, those who carried pathogenic or likely pathogenic mutations were at a 12-fold increased risk for subsequent breast cancer, a four-fold elevated risk of thyroid cancer and a 12-fold elevated risk of sarcoma compared to survivors without such mutations.

Retrospective study of a breast - conserving surgery with intra-operative radiotherapy, the UT - HSC experience

12 Scientific Sessions Radiochemistry: Imaging of Cancer Other Tumors Basic Science Summary Session One Myeloma and Other Marrow Disorders Radiopharmacy: Quality Control and Validation Radiotherapy and Monitoring Therapy Basic Science Summary Session Two Pre-Clinical Systems Breast Cancer Prostate I: Initial Staging Quantification and Methodology of Oncology Studies Novel Radiochemistry: Radiometals

The Department of Translational Research hosts 5 technological platforms (Genomics, Protein arrays, High - content screening, Experimental radiotherapy and Preclinical investigation), 4 labeled teams (resistance to therapy in breast cancers, translational pediatrics, angiogenesis, and immunotherapy) and 3 emergent teams (Circulating biomarkers, uveal melanoma, and new targets in triple negative breast cancers).

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Breast cancer cells, which survive in hypoxia, share many characteristics with breast cancer stem cells (CSC) such as loss of estrogen receptor - α (ER - α) expression (1), increased anoikis resistance (14) and increased resistance to radiotherapy and chemotherapy (15Breast cancer cells, which survive in hypoxia, share many characteristics with breast cancer stem cells (CSC) such as loss of estrogen receptor - α (ER - α) expression (1), increased anoikis resistance (14) and increased resistance to radiotherapy and chemotherapy (15breast cancer stem cells (CSC) such as loss of estrogen receptor - α (ER - α) expression (1), increased anoikis resistance (14) and increased resistance to radiotherapy and chemotherapy (15, 16).

Conventional medicine's main types of treatment for breast cancer include surgery, radiation therapy, external beam radiotherapy, chemotherapy, targeted therapy, and hormone therapy.

Enterolactone has also been found to increase the sensitivity of breast cancer cells to radiation, thereby potentially enhancing the treatment effects of radiotherapy.

This study recruited patients with Stages 0 to III breast cancer prior to starting radiotherapy.

Energy For Health - Volume 10 - Treatment with laser therapy of cutaneous damages induced by radiotherapy in breast cancer

Evidence - based recommendations report that 83 per cent of breast cancer patients should receive radiotherapy at some stage during their illness.

Adetoun's background is in therapeutic radiotherapy and breast cancer support, She also has experience and a special interest in working with clients presenting with attachment issues and childhood trauma and understands how to manage the clients» expectations.